Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL277442 | 1.00 | CPB2 (0.53) | CPB2CA2LMNAZDHHC7CA1 | |
| Methyl Alcohol SCHEMBL7668985 | 0.98 | CPB2 (0.51) | CPB2CA2LMNAZDHHC7CA1 | |
| Ammonia Solution, Strong SCHEMBL5121318 | 0.98 | CPB2 (0.51) | CPB2CA2LMNAZDHHC7CA1 | |
| SCHEMBL3845206 | 0.98 | CPB2 (0.50) | CPB2CA2LMNAZDHHC7CA1 | |
| Acetic Acid SCHEMBL3260364 | 0.95 | CPB2 (0.49) | CPB2CA2LMNAZDHHC7CA1 | |
| Ethyl Acetate SCHEMBL1279632 | 0.93 | CPB2 (0.47) | CPB2CA2LMNAZDHHC7CA1 | |
| Ethyl Acetate SCHEMBL5064725 | 0.93 | CPB2 (0.47) | CPB2CA2LMNAZDHHC7CA1 | |
| SCHEMBL3176263 | 0.92 | CA2 (0.52) | CPB2CA2CA1KDM4EDUSP3 | |
| Ethyl Acetate SCHEMBL17005456 | 0.90 | CPB2 (0.45) | CPB2CA2LMNAZDHHC7GRIK1 | |
| Ethyl Acetate SCHEMBL17699277 | 0.90 | CPB2 (0.45) | CPB2CA2LMNAZDHHC7GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117624307-A | Process for preparing cyclic organic compounds | 中外制药株式会社 | 2024-03-01 | — | — | CN | disclosed |
| EP-4271316-A1 | NOVEL ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | 3M Innovative Properties Company (US) | 2023-11-08 | — | — | EP | disclosed |
| US-11807664-B2 | Method for producing cyclic organic compound | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-07 | — | — | US | disclosed |
| CN-116635017-A | Novel antimicrobial compositions and articles made therefrom | 3M创新有限公司 | 2023-08-22 | — | — | CN | disclosed |
| WO-2022144664-A1 | NOVEL ANTIMICROBIAL COMPOSITIONS AND ARTICLES MADE THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-07-07 | — | — | WO | disclosed |
| US-20210147475-A1 | METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2021-05-20 | — | — | US | disclosed |
| EP-3623378-A1 | METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND | Chugai Seiyaku Kabushiki Kaisha (JP) | 2020-03-18 | — | — | EP | disclosed |
| CN-110799523-A | Process for preparing cyclic organic compounds | 中外制药株式会社 | 2020-02-14 | — | — | CN | disclosed |
| EP-2558446-B1 | NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS | AC IMMUNE SA (CH) | 2019-06-12 | — | — | EP | disclosed |
| CN-105008341-B | Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals | 赛诺菲 | 2017-10-24 | — | — | CN | disclosed |
| US-6391882-B1 | PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | H. LUNDBECK A/S (DK) | 2002-05-21 | — | — | US | disclosed |
| EP-1089997-A1 | 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE | H.Lundbeck A/S (DK) | 2001-04-11 | — | — | EP | disclosed |
| CN-1259119-A | Substituted 3, 3-diamino-2-propenenitriles, their preparation and use | NOVO NORDISK AS (DK) | 2000-07-05 | — | — | CN | disclosed |
| EP-1007523-A1 | INDOLE AND 2,3-DIHYDROINDOLE DERIVATIVES, THEIR PREPARATION AND USE | H. LUNDBECK A/S (DK) | 2000-06-14 | — | — | EP | disclosed |
| EP-0994107-A1 | 5-Arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | H. LUNDBECK A/S (DK) | 2000-04-19 | — | — | EP | disclosed |
| WO-1999067237-A1 | 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE | H. LUNDBECK A/S (DK) | 1999-12-29 | — | — | WO | disclosed |
| US-5955548-A | POTASSIUM CHANNEL MODULATORS | NOVO NORDISK A/S (DK) | 1999-09-21 | — | — | US | disclosed |
| WO-1999005140-A1 | INDOLE AND 2,3-DIHYDROINDOLE DERIVATIVES, THEIR PREPARATION AND USE | H. LUNDBECK A/S (DK) | 1999-02-04 | — | — | WO | disclosed |
| EP-0726896-A1 | 5-ARYLISOXAZOL-4-YL-SUBSTITUTED 2-AMINO CARBOXYLIC ACID COMPOUNDS | H. LUNDBECK A/S (DK) | 1996-08-21 | — | — | EP | disclosed |
| WO-1995012587-A1 | 5-ARYLISOXAZOL-4-YL-SUBSTITUTED 2-AMINO CARBOXYLIC ACID COMPOUNDS | H. LUNDBECK A/S (DK) | 1995-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147475-A1 | METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND | SCTR, CTRC, DCXR | CPB2 1106/4885CA2 1880/4885LMNA 4106/4885 |
| US-11807664-B2 | Method for producing cyclic organic compound | SCTR, CTRC, DCXR | CPB2 1106/4885CA2 1880/4885LMNA 4106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.